skip to the content

 

MabThera (rituximab)

Indicated for the treatment of certain types of non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, severe active rheumatoid arthritis and induction of remission in adult patients with severe, active Granulomatosis with polyangiitis (Wegener's) (GPA) and Microscopic polyangiitis (MPA).

(This is a brief indication for use; for details see SPC) 

SPC - Mabthera 100mg and 500mg Concentrate for Solution for Infusion
PIL - Mabthera 100mg and 500mg Concentrate for Solution for Infusion

Mabthera information at Medicine Guides